logo-large
  • Browse Categories

Publications by authors named "Michael Ero"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

308,243

Total Likes

8,307

Extended Reach

379,346

Social Features

20
I
Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.
Michael P Ero, Nathaniel R Harvey, Jack L Harbert, James W Janc, Kay H Chin

J Thromb Thrombolysis· February 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose.
Michael Penfield Ero, Connie M Ng, Tamara Mihailovski, Nathaniel R Harvey, Brad Howard Lewis

Altern Ther Health Med· August 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura.
Mervyn A Sahud, Susan Claster, Lucy Liu, Michael Ero, Kathryn Harris

Br J Haematol· March 2002


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: